Loading...
XNYS
MPLN
Market cap549mUSD
Dec 05, Last price  
33.95USD
1D
-8.12%
1Q
-51.37%
IPO
249.28%
Name

Multiplan Corp

Chart & Performance

D1W1MN
XNYS:MPLN chart
P/E
P/S
0.59
EPS
Div Yield, %
Shrs. gr., 5y
-33.59%
Rev. gr., 5y
-1.09%
Revenues
931m
-3.21%
1,067,266,0001,040,883,000982,901,000937,763,0001,117,602,0001,079,716,000961,524,000930,624,000
Net income
-1.65b
L+1,694.86%
648,132,00036,223,0009,710,000-529,626,000102,080,000-572,912,000-91,697,000-1,645,831,000
CFO
108m
-37.33%
368,945,000292,303,000284,313,000377,374,000404,687,000372,364,000171,720,000107,616,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment and revenue integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
IPO date
Feb 10, 2020
Employees
2,500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT